| 引用本文:黎元元 谢雁鸣.国外药品风险管理案例对制定中药注射剂上市后风险管理计划启示[J].世界中医药,2014,9(09):. |
|
| 国外药品风险管理案例对制定中药注射剂上市后风险管理计划启示 |
| Risk Management of the Postmarketing Chinese medicine Injections |
| 投稿时间：2014-08-06 |
| DOI：10.3969/j.issn.1673-7202.2014.09.004 |
| 中文关键词: 中药注射剂 风险管理 风险管理计划 案例 |
| English Keywords:Chinese medicine injection Risk management Risk management plan Case |
| 基金项目:“重大新药创制”科技重大专项“中药上市后再评价关键技术研究”（编号：2009ZX09502-030）；中国中医科学院科技创新团队建设项目(编号：PY1303) |
|
| 摘要点击次数: 1362 |
| 全文下载次数: 1727 |
| 中文摘要: |
| 随着中药注射剂的广泛应用，其不良反应也日渐引起重视。本文通过分析中药注射剂风险来源因素，以国内外药品风险管理的案例为借鉴，引入风险管理可以促进药品全过程安全管理的规范化与标准化，最大化药品的收益，最小化药品的风险，从而最终达到风险最小化的目的。 |
| English Summary: |
| Extensive use of traditional Chinese medicine injections has draw people’s eye toward adverse reactions, that is the reason in this research we analyzed various risk factors of traditional Chinese medicine injections, took examples from domestic and foreign drug risk management, and concluded introducing risk management can enhance safety control of a drug during the whole process of maximizing the drug benefits while minimizing various risks. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
